Abstract

We hypothesized that hypoxia may affect [Zn2+]I by activating a nitric oxide - metallothionein-zinc (NO-MT-Zn) pathway in SPAEC and labile [Zn2+]I in turn may affect targets such as PKC-ε. Microspectrofluorometric analysis of SPAEC exposed to low oxygen (PO2=24mmHg) revealed: a) an acute increase in labile (i.e. TPEN chelatable) [Zn2+]I that was sensitive to L-NAME (and partially reversible with supplemental L-arginine); and b) an unfolding (or release of zinc) of MT as determined from an acute decrease in efficiency of fluorescence resonance energy transfer (FRET) of an infected chimeric FRET. MT reporter. Exposure of SPAEC to exogenous zinc (1-10 μM) was associated with translocation of a transfected GFP-PKC-ε fusion protein to perinuclear localization. Biochemical confirmation revealed increases in immunoreactive PKC-ε in membrane compartments via Western blot from protein isolated from SPAEC exposed to exogenous zinc. Collectively these results are consistent with hypoxia causing S-nitrosation of MT. The resultant increase in labile [Zn2+]I may potentially result in activation of PKC-ε and accordingly, this potential new signaling pathway (NO-MT-Zn) in endothelial cells may affect PKC-ε dependent cellular responses to hypoxia. This research was supported in part by NIH HL 65697 (BRP) and Parker B. Francis FNDT (CMS)

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.